Rapamycin inhibits transforming growth factor beta 1 induced myofibroblast differentiation via the phosphorylated- phosphatidylinositol 3-kinase mammalian target of rapamycin signal pathways in nasal polyp-derived fibroblasts

被引:16
作者
Ko, Dong-Yn [1 ]
Shin, Jae-Min [1 ]
Um, Ji-Young [2 ]
Kang, Byungjin [1 ]
Park, Il-Ho [1 ]
Lee, Heung-Man [1 ,2 ,3 ]
机构
[1] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Guro Hosp, 148 Gurodong Ro, Seoul, South Korea
[2] Korea Univ, Coll Med, Div Brain, Korea Program Biomed Sci 21,Guro Hosp, Seoul, South Korea
[3] Korea Univ, Coll Med, Inst Korea Univ Med Devices Support Ctr, Guro Hosp, Seoul, South Korea
关键词
EXTRACELLULAR-MATRIX; DISEASE; MTOR; PROLIFERATION; ACCUMULATION; MECHANISMS; OUTCOMES;
D O I
10.2500/ajra.2016.30.4389
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose: Rapamycin has antiproliferative and antifibrogenic effects in vitro and in vivo. The purpose of this study was to evaluate the effects of rapamycin on transforming growth factor (TGF) beta 1 induced myofibroblast differentiation (alpha smooth-muscle actin [SMA]), extracellular matrix production, and collagen contraction in nasal polyp-derived fibroblasts (NPDF). The underlying molecular mechanisms of rapamycin were also determined in NPDFs. Methods: NPDFs were grown in culture and transformed into myofibroblasts by using TGF beta 1 (5 mu g/mL). For cytotoxicity evaluation, a 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-tetrazolium bromide assay was used. Expression levels of alpha SMA, phosphorylated phosphatidylinositol 3-kinase (PI3K), and phosphorylated mammalian target of rapamycin (mTOR) were determined by using Western blot, reverse transcription-polymerase chain reaction, and immunofluorescence staining. The total amount of collagen was analyzed by using the Sircol collagen assay, and contractile activity was measured with a collagen gel contraction assay. Silencing mTOR with mTOR-specific small interference RNA was determined by using reverse transcription-polymerase chain reaction. Results: Whereas rapamycin (range, 0-400 nM) had no significant cytotoxic effects on TGF beta 1 induced NPDFs, it significantly reduced the expression levels of alpha-SMA in TGF beta 1 induced NPDFs in a dose-dependent manner. TGF beta 1 induced collagen production and collagen contraction were significantly inhibited by rapamycin treatment. Rapamycin also attenuated the TGF beta 1 induced activation of PI3K and mTOR, and its inhibitory effects were similar to those of mTOR silencing and a specific PI3K inhibitor. Conclusions: Rapamycin inhibited TGF beta 1 induced myofibroblast differentiation, extracellular matrix production, and collagen contraction through the PI3K/mTOR signal pathways in NPDFs.
引用
收藏
页码:E211 / E217
页数:7
相关论文
共 28 条
  • [1] Nasal polyposis: From cytokines to growth
    Bachert, C
    Gevaert, P
    Holtappels, G
    Cuvelier, C
    van Cauwenberge, P
    [J]. AMERICAN JOURNAL OF RHINOLOGY, 2000, 14 (05): : 279 - 290
  • [2] The role of transforming growth factor β in lung development and disease
    Bartram, U
    Speer, CP
    [J]. CHEST, 2004, 125 (02) : 754 - 765
  • [3] Mechanisms of disease:: Role of transforming growth factor β in human disease.
    Blobe, GC
    Schiemann, WP
    Lodish, HF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) : 1350 - 1358
  • [4] Rapamycin Inhibits Hepatic Fibrosis in Rats by Attenuating Multiple Profibrogenic Pathways
    Bridle, Kim R.
    Popa, Claudia
    Morgan, Maelle L.
    Sobbe, Amy L.
    Clouston, Andrew D.
    Fletcher, Linda M.
    Crawford, Darrell H. G.
    [J]. LIVER TRANSPLANTATION, 2009, 15 (10) : 1315 - 1324
  • [5] A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling
    Chen, J
    Fang, YM
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 64 (07) : 1071 - 1077
  • [6] Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts
    Cho, J. -S.
    Moon, Y. -M.
    Park, I. -H.
    Um, J. -Y.
    Moon, J. -H.
    Park, S. -J.
    Lee, S. H.
    Kang, H. J.
    Lee, H. -M.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (06) : 872 - 882
  • [7] RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study
    Forwith, Keith D.
    Han, Joseph K.
    Stolovitzky, J. Pablo
    Yen, David M.
    Chandra, Rakesh K.
    Karanfilov, Boris
    Matheny, Keith E.
    Stambaugh, James W.
    Gawlicka, Anna K.
    [J]. INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2016, 6 (06) : 573 - 581
  • [8] Gao Y, 2013, YONSEI MED J, V54, P437, DOI [10.3349/ymj.2013.54.2.437, /10.3349/ymj.2013.54.2.437]
  • [9] Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase
    Holz, MK
    Blenis, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (28) : 26089 - 26093
  • [10] Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
    Jacinto, E
    Loewith, R
    Schmidt, A
    Lin, S
    Rüegg, MA
    Hall, A
    Hall, MN
    [J]. NATURE CELL BIOLOGY, 2004, 6 (11) : 1122 - U30